LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel: The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19.

    Gómez-Moyano, Elisabeth / Pavón-Morón, Javier / Rodríguez-Capitán, Jorge / Bardán-Rebollar, Daniel / Ramos-Carrera, Teresa / Villalobos-Sánchez, Aurora / Pérez de Pedro, Iván / Ruiz-García, Francisco J / Mora-Robles, Javier / López-Sampalo, Almudena / Pérez-Velasco, Miguel A / Bernal-López, Maria-Rosa / Gómez-Huelgas, Ricardo / Jiménez-Navarro, Manuel / Romero-Cuevas, Miguel / Costa, Francesco / Trenas, Alicia / Pérez-Belmonte, Luis M

    Journal of clinical medicine

    2024  Band 13, Heft 8

    Abstract: The therapeutic management and short-term consequences of the coronavirus disease 2019 (COVID-19) are well known. However, COVID-19 post-acute sequelae are less known and represent a public health problem worldwide. Patients with COVID-19 who present ... ...

    Abstract The therapeutic management and short-term consequences of the coronavirus disease 2019 (COVID-19) are well known. However, COVID-19 post-acute sequelae are less known and represent a public health problem worldwide. Patients with COVID-19 who present post-acute sequelae may display immune dysregulation, a procoagulant state, and persistent microvascular endotheliopathy that could trigger microvascular thrombosis. These elements have also been implicated in the physiopathology of postural orthostatic tachycardia syndrome, a frequent sequela in post-COVID-19 patients. These mechanisms, directly associated with post-acute sequelae, might determine the thrombotic consequences of COVID-19 and the need for early anticoagulation therapy. In this context, heparin has several potential benefits, including immunomodulatory, anticoagulant, antiviral, pro-endothelial, and vascular effects, that could be helpful in the treatment of COVID-19 post-acute sequelae. In this article, we review the evidence surrounding the post-acute sequelae of COVID-19 and the potential benefits of the use of heparin, with a special focus on the treatment of postural orthostatic tachycardia syndrome.
    Sprache Englisch
    Erscheinungsdatum 2024-04-20
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm13082405
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination.

    Molina-Ramos, Ana I / Gómez-Moyano, Elisabeth / Rodríguez-Capitán, Jorge / Angullo-Gómez, María / Gallardo-Jiménez, Patricia / Pérez de Pedro, Iván / Valiente de Santis, Lucía / Pérez-Villardón, Beatriz / Piñero-Uribe, Isabel / Mora-Robles, Javier / Becerra-Muñoz, Víctor Manuel / Jiménez-Navarro, Manuel

    Journal of clinical medicine

    2022  Band 11, Heft 23

    Abstract: The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is ... ...

    Abstract The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines.
    Sprache Englisch
    Erscheinungsdatum 2022-11-26
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11236999
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Effectiveness of a cardiac rehabilitation program on biomechanical, imaging, and physiological biomarkers in elderly patients with heart failure with preserved ejection fraction (HFpEF): FUNNEL + study protocol.

    Cuesta-Vargas, Antonio Ignacio / Fuentes-Abolafio, Iván José / García-Conejo, Celia / Díaz-Balboa, Estíbaliz / Trinidad-Fernández, Manuel / Gutiérrez-Sánchez, Daniel / Escriche-Escuder, Adrián / Cobos-Palacios, Lidia / López-Sampalo, Almudena / Pérez-Ruíz, Jose Maria / Roldán-Jiménez, Cristina / Pérez-Velasco, Miguel Angel / Mora-Robles, Javier / López-Carmona, Mª Dolores / Pérez-Cruzado, David / Martín-Martín, Jaime / Pérez-Belmonte, Luis Miguel

    BMC cardiovascular disorders

    2023  Band 23, Heft 1, Seite(n) 550

    Abstract: Background: Patients with heart failure with preserved ejection fraction (HFpEF) have a low functional status, which in turn is a risk factor for hospital admission and an important predictor of survival in HFpEF. HFpFE is a heterogeneous syndrome and ... ...

    Abstract Background: Patients with heart failure with preserved ejection fraction (HFpEF) have a low functional status, which in turn is a risk factor for hospital admission and an important predictor of survival in HFpEF. HFpFE is a heterogeneous syndrome and recent studies have suggested an important role for careful, pathophysiological-based phenotyping to improve patient characterization. Cardiac rehabilitation has proven to be a useful tool in the framework of secondary prevention in patients with HFpEF. Facilitating decision-making and implementing cardiac rehabilitation programs is a challenge in public health systems for HFpEF management. The FUNNEL + study proposes to evaluate the efficacy of an exercise and education-based cardiac rehabilitation program on biomechanical, physiological, and imaging biomarkers in patients with HFpEF.
    Methods: A randomised crossover clinical trial is presented among people older than 70 years with a diagnosis of HFpEF. The experimental group will receive a cardiac rehabilitation intervention for 12 weeks. Participants in the control group will receive one educational session per week for 12 weeks on HFpEF complications, functional decline, and healthy lifestyle habits. VO
    Discussion: Identifying objective functional parameters indicative of HFpEF and the subsequent development of functional level stratification based on functional impairment ("biomechanical phenotypes") may help clinicians identify cardiac rehabilitation responders and non-responders and make future clinical decisions. In this way, future pharmacological and non-pharmacological interventions, such as exercise, could be improved and tailored to improve quality of life and prognosis and reducing patients' hospital readmissions, thereby reducing healthcare costs.
    Trial registration: NCT05393362 (Clinicaltrials.gov).
    Mesh-Begriff(e) Humans ; Aged ; Cardiac Rehabilitation/methods ; Heart Failure/diagnostic imaging ; Heart Failure/therapy ; Quality of Life ; Stroke Volume ; Biomarkers ; Randomized Controlled Trials as Topic
    Chemische Substanzen Biomarkers
    Sprache Englisch
    Erscheinungsdatum 2023-11-10
    Erscheinungsland England
    Dokumenttyp Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2059859-2
    ISSN 1471-2261 ; 1471-2261
    ISSN (online) 1471-2261
    ISSN 1471-2261
    DOI 10.1186/s12872-023-03555-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang